Search - tctmd.com

Presenter: Daniela Trabattoni, piero montorsi, Franco Fabbiocchi, Giuseppe Calligaris, Alessandro Lualdi, Luca Grancini, Stefano Galli, Paolo Ravagnani, Giovanni Teruzzi, Antonio Bartorelli

January 31, 2013

Presentation TCT 2013

Randomized comparison of Biolimus-eluting (Nobori) and Everolimus-eluting (Xience/Promus) stents in patients with multivessel coronary artery disease: 12-month follow-up data...

Presenter: Peter Smits, A. J. van Boven, Mariano Valdes, Antonio Serra, Jean-Jacques Goy, V. Voudris, Ramiro Trillo, J. M. Vazquez, Peter den Heijer, Ton Slagboom, A.G. Vuillomenet

January 31, 2013

Presentation TCT 2013

Clinical Outcome in Chinese Patients with Long Lesion or Small Vessel / Multivessel Disease Receiving XIENCE V Everolimus-Eluting Stent: Early Results from the SEEDS Study

Presenter: Bo Xu, Yuejin Yang, Yaling Han, Bao Li, Qiang Liu, Guoying Zhu, Junyu Cui, Lang Li, Shuzheng Lu

January 31, 2013

News Daily News

La Duración Ideal de la Terapia Antiplaquetaria Doble podría Depender del Tipo de Stent

Jason Kahn

January 22, 2013

News Daily News

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Jason Kahn

January 22, 2013

News Industry News

Abbott Initiates Clinical Trial of Absorb™ in the United States

January 07, 2013

News Industry News

Abbott Announces FDA Approval and U.S. Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent System

January 02, 2013

Advertisement

NEXT Publicado: Los SLB de Polímero Biodegradable No son Inferiores a los SLE

TWENTE: Still Few Differences between ZES and EES at 2 Years

TWENTE: Sigue habiendo Pequeñas Diferencias entre los SLZ y los SLE a los 2 Años

Conversations in Cardiology: Brief Question re: BMS-DES and DAPT

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

Three-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents

Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES

Double-Kissing Crush Better than Culotte Technique for Left Main Bifurcation Stenting

Los SLE No son Inferiores a los SLS en el Tratamiento de las Oclusiones Coronarias Totales

EES Noninferior to SES for Treating Total Coronary Occlusions

Underpowered Study Finds Differences Between CABG, PCI in Diabetics

Un Estudio No dotado de las Herramientas necesarias Halla Diferencias entre la CABG y la PCI en Diabéticos

Promus PREMIER™ Everolimus-Eluting Platinum Chromium Stent System Receives CE Mark Approval

Tryton-Xience for the Treatment of Complex Coronary Bifurcation Lesions: A Single Center Consecutive Series

Randomized comparison of Biolimus-eluting (Nobori) and Everolimus-eluting (Xience/Promus) stents in patients with multivessel coronary artery disease: 12-month follow-up data...

Clinical Outcome in Chinese Patients with Long Lesion or Small Vessel / Multivessel Disease Receiving XIENCE V Everolimus-Eluting Stent: Early Results from the SEEDS Study

La Duración Ideal de la Terapia Antiplaquetaria Doble podría Depender del Tipo de Stent

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Abbott Initiates Clinical Trial of Absorb™ in the United States

Abbott Announces FDA Approval and U.S. Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content